A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
We are doing this study to see if cilta-cel is safe and effective when it doesn't meet all the normal standards.
We are doing this study to see if cilta-cel is safe and effective when it doesn't meet all the normal standards.
*Third Opinion AI Generated Synopsis
Trial Summary
The purpose of this study is to evaluate the efficacy and safety of cilta-cel out-of-specification (OOS).
The purpose of this study is to evaluate the efficacy and safety of cilta-cel out-of-specification (OOS).
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: